Investor presentations

Presentation of the Q1 Interim report 2023

May 2, 2023

Oncopeptides AB (publ) published the report for the first quarter 2023, at 08.00 (CET) on Thursday May 4, 2023. Investors, financial analysts, and media were invited to participate in a webcast and a...

Read more

Presentation of the year-end report 2022

February 9, 2023

Oncopeptides AB (publ) published the report for the fourth quarter and the 2022 year-end report, on February 16, 2023. Investors, financial analysts, and media were invited to participate in a webcas...

Read more

DNB Healthcare Conference 2022 - presentation

December 15, 2022

On December 15, 2022, Oncopeptides CCO and Managing Director Germany, Sofia Heigis, gave a presentation at the DNB Healthcare Conference in Oslo, together with Dr. Fredrik Schjesvold from the Oslo Mye...

Read more

Fire side chat with CEO Jakob Lindberg at SEB's Annual Healthcare Seminar 2022

November 23, 2022

At SEB's Annual Healthcare Seminar 2022 Jakob Lindberg, CEO Oncopeptides, participated in a fire side chat with Dr. Christopher Uhde, Pharma/Biotec equity research at SEB.

Read more

Webcast - presentation of the Q3 report 2022

November 7, 2022

Oncopeptides publishes its report for the third quarter 2022 on November 9 at 08.00 (CET). On the same day at 14:00 (CET) investors, analysts, and media are invited to participate in a webcast and a ...

Read more

German launch - press conference

October 21, 2022

Read more

Webcast - update from the ODAC meeting, Sep 22

September 23, 2022

September 23, 2022, the Oncologic Drugs Advisory Committee (ODAC), of the US Food and Drug Administration (FDA), has finalized the discussion on the benefit-risk profile of Pepaxto® (melphalan flufena...

Read more

Webcast - presentation of the Q2 Interim Report 2022

August 9, 2022

Oncopeptides published its report for the second quarter 2022 on August 11, 2022, and hosted a webcast on the same day at 14:00 CET.

Read more

Webcast - CHMP rekommenderar att Oncopeptides Pepaxti får ett fullt godkännande i EU

June 23, 2022

June 23, 2022, the European Medicines Agency´s (EMA) Committee for Medicinal Products for Human Use (CHMP), has unanimously adopted a positive opinion recommending a full marketing authorization appro...

Read more

How do you manage expectations and communicate setbacks as a small, listed biotech company? - CEO sitdown with Jakob

June 1, 2022

CEO Jakob Lindberg took part in a webcast called CEO sitdown at Paues Åberg June 1, 2022. The interview is moderated by Caroline Wiken, partner at Paues Åberg.

Read more

ABGSC Life Science Summit 2022

May 19, 2022

Oncopeptides CEO Jakob Lindberg presented at the ABGSC Life Science Summit 2022, May 19.

Read more

Webcast - Presentation of the Q1 Interim Report 2022

April 27, 2022

Read more

Carnegie Healthcare Seminar 2022

March 17, 2022

Oncopeptides CEO Jakob Lindberg presented at Carnegie Healthcare Seminar 2022, March 17 at 16.45 CET. See the presentation below.

Read more

Webcast - Presentation of the Year-end Report 2021

February 14, 2022

Oncopeptides published its report for the fourth quarter and year-end results 2021 on February 17, 2022, and hosted a webcast on the same day at 15:00 CET. 

Read more

Webcast - Oncopeptides rescinds voluntary withdrawal of Pepaxto

January 21, 2022

January 21, 2022, Oncopeptides announced that the Company has contacted the US Food and Drug Administration and rescinded the October 22, 2021, letter requesting voluntary withdrawal of the NDA of Pep...

Read more

Webcast - Presentation of the Q3 Interim Report 2021

November 19, 2021

Oncopeptides published its report for the third quarter 2021 on November 24, 2021, and hosted a webcast on the same day at 10:00 CET. 

Read more

Jakob interviewed by Di.TV - as new CEO about going forward

November 15, 2021

In conjunction with the anouncement of Jakob Lindberg as new CEO of Oncopeptides, he was interviewed by the Swedish economy TV channel Di.TV about the company's priorities going forward.

Read more

Webcast - Oncopeptides withdraw Pepaxto® in US, scale down organization and focus on R&D

October 22, 2021

October 22, 2021, Oncopeptides announced that the company has decided to withdraw Pepaxto® from the market in the US. The decision has been made after interactions and dialogue with the US Food and Dr...

Read more

Handelsbanken Healthy Hour - presentation

September 15, 2021

Oncopeptides presented at Handelsbanken Healthy Hour on September 15. The presentation was held by CEO Marty J Duvall, CSO Klaas Bakker and CFO Anders Martin-Löf.

Read more

Webcast for presentation of OCEAN data presented at IMW

September 9, 2021

Oncopeptides presented data from the OCEAN study at the 18th International Myeloma Workshop (IMW) on September 11. Investors, financial analysts, and media were invited to participate in a webcast inc...

Read more

Presentation of the Q2 Interim Report 2021

August 12, 2021

Oncopeptides has published its report for the second quarter 2021 on August 19, 2021, and hosted a webcast on the same day at 12:00 CEST. 

Read more

Presentation updated OCEAN data

July 8, 2021

Oncopeptides hosted a webcast on July 8, 2021, at 11:00 (CET) including presentations by CEO Marty J Duvall, CSO Jakob Lindberg, and CMO Klaas Bakker.

Read more

Redeye Growth Day 2021 presentation

June 2, 2021

Oncopeptides' CFO Anders Martin-Löf presented at Redeye Growth Day 2021 , June 2.

Read more

Presentation of the Q1 Interim Report 2021

May 26, 2021

Oncopeptides has published the Q1 Interim Report 2021 and hosted a webcast the same day at 12:00 (CET), May 26, 2021. 

Read more

Webcast - presentation of OCEAN topline data, May 25, 2021

May 25, 2021

In conjunction with the release of the topline data of the OCEAN study, Oncopeptides hosted a webcast May 25, 2021, at 11:00 (CET), including presentations by CEO Marty J Duvall, CSO Jakob Lindberg, C...

Read more

Theme Day Commercialization of Medicine - Erik Penser Bank

May 6, 2021

Oncopeptides's CFO Anders Martin-Löf presented at Erik Penser Bank's theme day Commercialization of medical component on May 6 at 16:15 CET. The theme day was broadcasted live 09:00-17:00 CET. Welcome...

Read more

Aktiedagen Stockholm - Aktiespararna

May 4, 2021

Oncopeptides's CFO Anders Martin-Löf presented at Aktiespararna's event Aktiedagen Stockholm on May 4 at 13:30 CET. The share day was broadcasted live from 07: 50-20:00 CET and 18 listed companies par...

Read more

Cowen 41st Annual Health Care Conference - presentation

March 3, 2021

Oncopeptides' CEO Marty J Duvall presented at the Cowen 41st Annual Health Care Conference, March 3, 2021, at 17.00 CET. The presenation is webcasted, see link below.

Read more

Company Presentation March 2021

March 3, 2021

New Company Presentation for Oncopeptides, March 2021.

Read more

FDA approval of PEPAXTO - Webcast for investors, analysts and the media

March 1, 2021

In conjunction with the FDA approval of PEPAXTO February 26, Oncopeptides hosted a webcast March 1, 2021, at 07:30 (CET), including presentations by CEO Marty J Duvall, CSO Jakob Lindberg, CMO Klaas B...

Read more

Webcast Year-end Report 2020 presentation

February 18, 2021

Oncopeptides held a webcast February 18, 2021 at 14:00 (CET) when the Year-end Report 2020 and an operational update was presented by CEO Marty J Duvall, CMO Klaas Bakker and CFO Anders Martin-Löf.

Read more

Oncopeptides Virtual Capital Markets Day

November 30, 2020

“Building a Fully Integrated Biotechnology Company”

Read more

Jefferies London Health Care Conference presentation

November 18, 2020

Marty J Duvall presents at Jefferies London Health Care Conference, Wednesday December 18, 2020. The webcast is recorded. See presentation and link below.

Read more

DNB investor presentation

November 9, 2020

Read more

Citi’s 15th Annual BioPharma Virtual Conference – Presentation

September 10, 2020

Oncopeptides' CEO Marty J Duvall and CSO Jakob Lindberg presented at Citi’s 15th Annual BioPharma Virtual Conference. Please see attached presentation below.

Read more

Pareto Securities 11:e Healthcare Conference – Presentation

September 2, 2020

Oncopeptides' CEO Marty J Duvall and CSO Jakob Lindberg presented at Pareto Securities Healthcare Conference. Please see attached presentation.

Read more

Webcast regarding operational update Q2 2020

August 26, 2020

Oncopeptides held an operational update Wednesday August 26, 2020. It was presented by CEO Marty J Duvall, CSO Jakob Lindberg and CFO Anders Martin-Löf. The presentation was also recorded, see link be...

Read more

Nordea Small Cap Seminar – Presentation

August 12, 2020

Oncopeptides presented at Nordea Small Cap Seminar on Aug 12, 2020. See presentation below.

Read more

Jefferies Healthcare Conference June 3, 2020

June 3, 2020

Oncopeptides CEO presents at 1.30 – 1.55 PM (EDT) (19.30-19.55 CEST). See attached presentation, and click the link below to come to the webinar.

Read more

Webcast regarding operational update Q1 2020

May 26, 2020

Oncopeptides held an operational update Tuesday May 26, 2020. It was presented by CEO Jakob Lindberg and members of Oncopeptides management team. The presentation was recorded, see link below.

Read more

Company Presentation April May 2020

April 27, 2020

Read more

Company Presentation March April 2020

March 31, 2020

Read more

Stockholm Corporate Finance Life Science Day – presentation

March 11, 2020

Oncopeptides’ CFO Anders Martin-Löf presented at the Stockholm Corporate Finance Life Science Day, March 11, 2020. See the recording of the presentation, and the presentation below.

Read more

Webcast Year-End Report 2019

February 20, 2020

Read more

Presentation at SEB Annual Pharma & Biotech Seminar 2020

January 22, 2020

Read more

2020 J.P. Morgan Health Care Conference – Presentation

January 21, 2020

San Francisco, 13-16 January 2020

Read more

Avanza Lunch Presentation

November 27, 2019

Oncopeptides’ CEO Jakob Lindberg presented at the Avanza Lunch meeting.

Read more

Investing in Oncology Forum 2019

October 7, 2019

Oncopeptides’ CFO Anders Martin-Löf held a presentation at Investing in Oncology Forum 2019 in Stockholm, Sweden, on October 7.

Read more

Corporate Presentation, 3 October 2019

October 3, 2019

Read more

Pareto Health Care Conference 2019

September 5, 2019

Oncopeptides AB (publ) presented at the Pareto Securities Health Care Conference 2019. See attached presentation.

Read more

Corporate Presentation, 17 June 2019

June 17, 2019

Read more

REDEYE Growth Day – Presentation

June 10, 2019

Oncopeptides CFO Anders Martin-Löf held a presentation at the REDEYE Growth Day, 10 June 2019. The Presentation was recorded and can be showed at the link below.

Read more

Jefferies 2019 Healthcare Conference, New York – Presentation

June 5, 2019

Oncopeptides CEO Jakob Lindberg gave a presentation at Jefferies Healthcare Conference in New York June 7, at 17.30 CET. The presentation was webcasted, see link below. You can also listen to the pres...

Read more

REDEYE Pre-ASCO Seminar – presentation

May 28, 2019

CEO Jakob Lindberg presented at the REDEYE Pre-ASCO Seminar, Tuesday May 28, in Stockholm, Sweden. See link to the recording of the presentation below.

Read more

Webcast regarding operational update

May 21, 2019

Oncopeptides held an operational update on Tuesday, May 21, 2019, at. 10:00 (CET). It was presented by CEO Jakob Lindberg and members of the Oncopeptides management team. The webcast was recorded. See...

Read more

Webcast regarding clinical program update

April 24, 2019

Oncopeptides held an webcast April 24, 2019, where CEO Jakob Lindberg provided new guidance on the patient recruitment in the OCEAN study and a clinical program update. The webcast was recorded. See t...

Read more

Kempen Life Science Conference 2019 – presentation

April 16, 2019

Oncopeptides presented at the Kempen Life Science Conference 2019 in Amsterdam, Netherlands.

Read more

Cowen & Company 39th Annual Health Care Conference – Presentation

March 11, 2019

CEO Jakob Lindberg presented at Cowen and Company 39th Annual Health Care Conference on March 11, 2019. The presentation was webbcasted, see link below.

Read more

Carnegie Healthcare Conference 2019 – presentation

March 6, 2019

CEO Jakob Lindberg presented at Carnegie Healthcare Conference, on March 6 2019.

Read more

Webcast Year-End Report 2018

February 22, 2019

The Year-end Report for 2018 and an operational update was presented by CEO Jakob Lindberg and members of Oncopeptides management team, February 22, 2019 at 14:00 (CET).

Read more

SEB Biotech Seminar – presentation

January 24, 2019

By Jakob Lindberg, CEO, Oncopeptides AB (publ).

Read more

2019 J.P. Morgan Health Care Conference – Presentation

January 16, 2019

San Francisco, January 7-10, 2019.

Read more

Oncopeptides Capital Markets Day in New York – presentations

December 14, 2018

Oncopeptides did host a Capital Markets Day on December 14th between 8.30-11.00 AM ET in New York, here is the presentation from the whole day. Speakers were Jakob Lindberg, Chief Executive Officer, o...

Read more

DNB Nordic Healthcare Conference 2018 – presentation

December 13, 2018

December 12, CEO Jacob Lindberg held a presentation at the DNB Nordic Healthcare Conference 2018 in Oslo.

Read more

Jakob Lindberg, CEO, Oncopeptides – Company presentation post ASH

December 6, 2018

Jakob Lindberg, CEO, Oncopeptides – Company presentation post ASH 2018.

Read more

Jefferies 2018 London Healthcare conference – Presentation & webcast

November 14, 2018

Oncopeptides CEO Jakob Lindberg held a presentation at Jefferies 2018 Healthcare conference in London November 14. The presentation was also recorded. Click on the recording (mp3-file) to view the Web...

Read more

Lunch presentation at DNB

September 25, 2018

Corporate presentation by Jakob Lindberg, CEO, Oncopeptides AB (publ), at DNB 25 September 2018.

Read more

Jefferies Health Care conference, New York – Presentation

June 7, 2018

Oncopeptides CEO Jakob Lindberg held a presentation at Jefferies Healthcare Conference in New York June 7.

Read more

Jakob Lindberg, CEO, is interviewed in Di tv

May 17, 2018

Read more

Carnegie Healthcare Seminar 2018 – presentation

March 14, 2018

Oncopeptides CEO Jakob Lindberg held a presentation at Carnegie Healthcare Seminar on March 14.

Read more

SCF Life Science Seminarium – presentation

March 7, 2018

Oncopeptides CEO Jakob Lindberg held a presentation at Stockholm Corporate Finance Live Science Seminarium March 7.

Read more

ABGSC Orphan Drug Day 2018 – Presentation

February 22, 2018

Oncopeptides presentation at the ABG Office in Stockholm, Sweden.

Read more

Jakob Lindberg interviewed in DI Börsmorgon

January 25, 2018

Oncopeptides CEO Jakob Lindberg is being interviewed in DI Börsmorgon, January 25, 2018.

Read more

JP Morgan, San Francisco – Presentation

January 12, 2018

January 8-10, 2018.

Read more

DNB Nordic Healthcare Conference 2017 – Oslo

December 14, 2017

Oncopeptides’ presentation at DNB in Oslo, 14 December.

Read more

Carnegie Healthcare Day in New York – presentation

December 6, 2017

Oncopeptides presentation at Carnegie, New York, 5 December 2017.

Read more

Lunch at ABG – presentation

November 15, 2017

Presentation at ABG.

Read more

Pareto Securities Healthcare conference 2017 – Presentation

September 7, 2017

Read more

Annual General Meeting 2017 – Presentation

May 18, 2017

Read more

DNB SME Conference 2017

April 5, 2017

Read more

Carnegie Health Care Seminar

March 16, 2017

Read more

Redeye – Fight cancer-event

March 10, 2017

Read more

Press release -

The Swedish Economic Crime Authority terminates the investigation of Oncopeptide's Chief Scientific Officer Jakob Lindberg

Read press release
Events Oncopeptides

Upcoming events

View calendar

Oncopeptides via e-mail